Extracellular vesicles (EVs), as a cutting-edge focus in the field of biomedicine, are continuously driving the industrial innovation landscape with their unique potential in disease diagnosis and treatment. The "2025 (Shenzhen) Extracellular Vesicle Conference" will be held at the Sheraton Grand Hotel in Shenzhen on June 27-28. This professional event, which focuses on EVs research and industrial transformation, has already attracted widespread attention from the industry.

EVs, carrying substances such as proteins and nucleic acids, play a key role in tumor pathophysiology and show great clinical transformation value in directions such as liquid diagnosis and drug delivery. However, it still faces the challenge of slow progress in the field of tumor immunotherapy. This conference directly addresses the pain points of the industry, deeply focusing on two core directions: "Breakthroughs in extracellular vesicles and Tumor immunotherapy" and "Expansion of multi-disease diagnosis and Treatment Applications". It gathers global scientific research forces and industrial pioneers to decode the underlying logic of EVs reshaping the tumor microenvironment, precisely delivering drugs, and regulating the immune system, accelerating the leap from basic research to clinical application. In June in Shenzhen, this industry event focusing on the cutting-edge and transformation is highly anticipated by global biopharmaceutical practitioners!

Bio-Gene as the national agent of Apogee in China, its main product ApogeeFlow Micro Plus  has attracted much attention in the past industry activities. In this exhibition, Bio-Gene will join hands with ApogeeFlow to participate in and sponsor the exhibition. In this exhibition, Bio-Gene will show the company's flagship products during the conference: ApogeeFlow Micro Plus. There are special sales and technical personnel to demonstrate the operation and answer questions. Welcome the scientists and researchers to visit the booth A36!

Product preview